0
Sickle Cell Care Expansion Act of 2022
12/29/2022, 10:03 PM
Summary of Bill HR 7177
The key provisions of the bill include increasing funding for research and treatment of sickle cell disease, improving access to specialized care centers, and enhancing education and training for healthcare providers. The bill also seeks to address disparities in healthcare access and outcomes for individuals with sickle cell disease, particularly in underserved communities.
Additionally, the Sickle Cell Care Expansion Act of 2022 aims to promote early detection and intervention for individuals with sickle cell disease, as well as improve coordination of care between healthcare providers and patients. The bill emphasizes the importance of a holistic approach to managing sickle cell disease, including mental health support and social services. Overall, the Sickle Cell Care Expansion Act of 2022 is a comprehensive piece of legislation that seeks to improve the quality of life for individuals with sickle cell disease and ensure that they receive the care and support they need to manage their condition effectively.
Congressional Summary of HR 7177
Sickle Cell Care Expansion Act of 2022
This bill establishes programs to increase treatment and other services for populations with sickle cell disease. Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.
Specifically, the Department of Health and Human Services must award grants to federally qualified health centers, community-based organizations, or other nonprofits that treat or otherwise support populations with sickle cell disease for education and advocacy programs concerning the disease.
Additionally, the Health Resources and Services Administration must establish a program to provide scholarships or student loan repayment awards to individuals who commit to engage in clinical practice or research related to sickle cell disease for a period of obligated service as physicians.
